期刊文献+

两种不同的方法治疗早期糖尿病肾病疗效分析

A Curative Effects of in Early Diabetic Nephropathy by Two Treatment Methods
下载PDF
导出
摘要 目的探讨两种不同的方法治疗早期糖尿病肾病的临床疗效。方法 150例早期糖尿病肾病(DN)患者随机对照组75例和治疗组75例,两组患者在常规降糖药物和(或)降压药物治疗的基础上,治疗组给缬沙坦80mg/d,口服,同时给氟伐他汀40mg/d,口服;对照组给缬沙坦80mg/d,口服。两组疗程3个月。比较两组治疗前及治疗后尿白蛋白排泄率(UAER)、血肌酐(Scr)和反应蛋白(CRP)等指标。结果对照组治疗后SBP、DBP、UAER含量[(123.22±11.54)mmHg、(70.11±9.89)mmHg、(130.58±20.86)μg/min]低于治疗前[(130.22±9.21)mmHg、(76.56±8.22)mmHg、(145.78±25.44)μg/min](t=2.145,t=2.214,t=2.211,P均<0.0.5);治疗组治疗后UAER、CRP含量[(102.71±21.11)μg/min、(3.83±1.41)mg/L]明显低于治疗前[(144.44±24.12)μg/min、(7.13±1.64)mg/L](t=2.845,t=2.914,P均<0.05);治疗组治疗后UAER、CRP与对照组比较有显着性差异(t=2.014,t=2.25,P均<0.05)。结论氟伐他汀具有降低CRP的抗炎效应,与缬沙坦联用对早期糖尿病肾病进行干预治疗,可有效地降低尿清蛋白排泄率,保护肾功能。 Objective To investigate the curative effects in early diabetic nephropathy (EDN)by two treatment way. Methods 150 cases with EDN were divided into two groups, the control group(n=75) and the treated group (n=75).Two groups were strictly enforced in the diabetic diet, low-quality protein intake, conventional hypoglycemic drug and/or blood pressure medication treatment. The therapy group was given the valsartan80mg/d,orally, at the same time to fluvastatin 40mg/d, ora; l while the control group was given the valsartan 80mg/d, ora.l Two groups were treated for 3 months. Compare the index of UAER, Scr and CRP respectively. Results The contents of SBP, DBP, UAER in control group after treatment[(123.22±11.54)mmHg、(70.11±9.89)mmHg, (130.58 ±20.86)μg/min] were signifi cantly lower than before treatment[(130.22±9.21)mmHg, (76.56±8.22)mmHg, (145.78±25.44)μg/min] (t=2.145, t=2.214, t=2.211, P al〈l0.05);The contents of UAER, CRP in treatment group after treatment[(102.71±21.11)μg/ min, (3.83±1.41)mg/L] was signifi cantly lower than before treatment[(144.44±24.12)μg/min, (7.13±1.64)mg/L](t=2.845, t=2.914, P all〈0.05);The contents of UAER, CRP in treatment group compared with the control group there were signifi cant difference(t=2.014, t=2.25, P all〈0.05).Conclusion Fluvastatin combined with valsartan as early intervention therapy on the DN can be more effective in reducing urinary album in excretion rate and protect the renal function.
出处 《中国医药指南》 2010年第24期28-29,共2页 Guide of China Medicine
关键词 糖尿病肾病 氟伐他汀 缬沙坦 疗效 Fluvastatin Valsartan Early diabetic nephropathy Curative effects
  • 相关文献

参考文献9

二级参考文献73

  • 1高苹,贾汝汉,宋恩峰,褚瑰丽,丁国华.氟伐他汀、缬沙坦及两药合用对糖尿病大鼠肾小管间质病变的保护作用[J].中华肾脏病杂志,2004,20(3):218-219. 被引量:12
  • 2江启蓉,叶云,戚明双.氟伐他汀的非降脂作用及用途[J].中国药物与临床,2004,4(10):783-784. 被引量:2
  • 3何冰,韩萍,吕先科.2型糖尿病患者急性时相蛋白与糖尿病肾病的关系[J].中华内分泌代谢杂志,2003,19(4):260-262. 被引量:170
  • 4阳琰,高琳.血脂代谢异常与糖尿病视网膜病变及糖尿病肾病的关系[J].湖北民族学院学报(医学版),2007,24(1):34-36. 被引量:6
  • 5中华医学会眼科学会眼底病学组.糖尿病视网膜病变分期标准[J].眼底病,1985,1:42-42.
  • 6Aoyama I, Shimokata K, Niwa T. An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats. Nephron,2002, 92: 635-651.
  • 7Usui H, Shikata K, Matsuda M, et al.HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant,2003, 18: 265-272.
  • 8Zoja C, Corna D, Rottoli D, et al. Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Kidney Int, 2002, 61: 1635-1645.
  • 9Barziay J I, Abraham L, Heckbert S R, et al. The relation ofmarkers of in tlammation to development of glucose disorders in the elderly: the cardio vascular health study [ J]. Diabetes ,2001,50(10) :384 - 389.
  • 10RomanoM, PomilioM, Vigneri S, et al. Endothelial paeturbation in chil2dren and with type 1 diabetes: association with markers of the inflammato2ry reaction [ J ]. Diabetes Care,2001,24(9) :1674 - 1678

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部